|
Alex Meissner
answers a
few questions about this month's fast breaking paper in
the Multidisciplinary field.
From
•>>October 2006
Field:
Multidisciplinary
Article Title: Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts
Authors: Meissner,
A;Jaenisch, R
Journal: NATURE
Volume: 439
Issue: 7073
Page: 212-215
Year: JAN 12 2006
* MIT, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.
* MIT, Whitehead Inst, Cambridge, MA 02142 USA.
* MIT, Dept Biol, Cambridge, MA 02142 USA.
|
Why
do you think your paper is highly cited?
|

|
|
“Our
paper described a modification of the current NT
procedure, which would allow generating ES cells
without destroying an embryo.”
|
|
The derivation of embryonic
stem cells in the US and abroad is very controversial. One
potential way to generate "customized" embryonic stem
(ES) cells is through nuclear transfer (NT). Our paper described
a modification of the current NT procedure, which would allow
generating ES cells without destroying an embryo. This is
achieved by blocking a gene that is essential for
placental-development. The proof of the principle of this
approach was demonstrated in a mouse model.
Does
it describe a new discovery, methodology, or synthesis of
knowledge?
It describes a number of previously described techniques that
were combined to achieve the goal of reversibly blocking a gene
that is required for the development of the extra-embryonic
lineage, which will later form the placenta.
Could
you summarize the significance of your paper in layman’s terms?
The paper is important, as it describes the first alternative
approach ("altered nuclear transfer") that could be
used to generate "customized" ES cells without
destroying an embryo, as demonstrated in the mouse.
By blocking a gene that is required for the extra-embryonic
cells prior to the nuclear transfer, only a disorganized clump
of cells develops. This clump, however, still contains the cells
that can be expanded into ES cells.
How
did you become involved in this research, and were any problems
encountered along the way?
The development of our procedure was only possible through
combining a number of recently developed tools. Our lab is one
of the few labs that had all the tools in place—nuclear
transfer, RNA interference, etc.—and also has a major focus on
stem cell biology.
Are
there any social or political implications for your research?
The key issue is whether the "Altered Nuclear
Transfer" (ANT) product is an embryo or a biological
artifact, as William B. Hurlbut, a physician and consulting
professor in the program of human biology at Stanford
University, is arguing.
We have now gotten reactions by a number of ethicists,
Catholic scholars, and even members of the Bush Administration,
that they would not consider the ANT product as an embryo. This
may open up funding from NIH for this type of research.
Obviously, this is a highly charged political issue and we will
have to see where this public discussion goes.
Alex Meissner, Ph.D.
Whitehead Institute for Biomedical Research
MIT
Cambridge, MA, USA
|
ESI Special Topics,
October 2006
Citing URL - http://www.esi-topics.com/fbp/2006/october06-AlexMeissner.html
|
|